The field tests in the last year show that the items on the whole are performing as intended, and patients find the surveys acceptable and feasible. There is growing interest in the research community to use these instruments, and we have been exploring interest in clinical community to extend their use.
Posted in Decision Quality, Directed Research, Patient Knowledge, Patient Preferences
Tagged breast cancer, colorectal cancer screening, decision quality instruments, depression, herniated disc, hip osteoarthritis, knee osteoarthritis, menopause, MGH
Our primary hypothesis is that participants who utilize the “Early Breast Cancer: Chemotherapy and Hormone Therapy are They Right for You?” (translated) DA in shared decision- making will experience more value-congruent decisions than the control group. The specific aims of the proposed work are to: 1) determine the utility of the DA in decision-making; 2) evaluate satisfaction with the DA; and 3) assess and compare the participant’s satisfaction with and value-congruence of her decision after exposure to the DA with those of the control group.
The main goals of this study, using breast cancer patients stages IA to IIIB, are to assess: 1) the degree to which an alternative method of visually presenting and summarizing the numerical data provided by “Adjuvant” influence realistic treatment expectations; 2) the degree to which numeracy affects treatment expectation and through what mechanisms and; 3) whether methods of presenting and summarizing the “Adjuvant” data differentially influence treatment expectations as a function of numeracy.